Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 3
1 (25.0%)Evaluation of the Effects of a Food Supplementation on the Improvement of Cognitive Functions in Healthy Seniors
Not Applicable
Completed
- Conditions
- Healthy Subjects
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Bionov
- Target Recruit Count
- 144
- Registration Number
- NCT05472285
- Locations
- 🇫🇷
Clinical Investigation Unit Biofortis - Paris, Paris, France
🇫🇷Clinical Investigation Unit of Biofortis - SHE, Saint-Herblain, France
Evaluation of SODB® (Superoxide Dismutase by Bionov®) in the Physical Condition Improvement in Healthy Subjects
Not Applicable
- Conditions
- Healthy Volunteers
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2016-08-26
- Lead Sponsor
- Bionov
- Target Recruit Count
- 42
- Registration Number
- NCT02880657
Evaluation of SODB® in Metabolic Adaptations in Overweight Women
Not Applicable
- Conditions
- Overweight
- First Posted Date
- 2016-01-29
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Bionov
- Target Recruit Count
- 32
- Registration Number
- NCT02667691
Multicentre, Double-blind Study Versus Placebo on Impact and Safety of Extramel® 140 IU on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception if Present, and the Impact on the Quality of Life
Phase 3
Completed
- Conditions
- Life StressFatiguePainQuality of Life
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Bionov
- Target Recruit Count
- 61
- Registration Number
- NCT01767922
News
No news found